Patents Assigned to Anvyl LLC
  • Deuterated analogs of etifoxine, their derivatives and uses thereof
    Patent number: 10080755
    Abstract: This invention relates to deuterated analogs of etifoxine of Formula 1, solvates, prodrugs, and pharmaceutically acceptable salts thereof, as well as to methods for their preparation and use, and to pharmaceutical compositions. Briefly, this invention is generally directed to deuterated analogs of etifoxine as well as to methods for their preparation and use, and to pharmaceutical compositions containing the same.
    Type: Grant
    Filed: March 18, 2016
    Date of Patent: September 25, 2018
    Assignee: ANVYL, LLC
    Inventor: Olivier Dasse
  • Alpha 7 Nicotinic Acetylcholine Receptor Allosteric Modulators, Their Derivatives and Uses Thereof
    Publication number: 20150099758
    Abstract: The present application is related to compounds represented by Formula I, which are novel positive allosteric modulators of al nAChRs. The application also discloses the treatment of disorders that are responsive to enhancement of acetylcholine action on al nAChRs in a mammal by administering an effective amount of a compound of Formula I.
    Type: Application
    Filed: May 8, 2013
    Publication date: April 9, 2015
    Applicant: Anvyl LLC
    Inventors: David Putnam, Olivier Dasse
  • ?7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof
    Patent number: 8975407
    Abstract: The present application is related to compounds represented by Formula I, which are novel allosteric modulators of ?7nAChR.
    Type: Grant
    Filed: October 8, 2013
    Date of Patent: March 10, 2015
    Assignee: Anvyl LLC
    Inventor: Richard Kanner
  • Alpha-7 Nicotinic Acetylcholine Receptor Allosteric Modulators, Their Derivatives and Uses Thereof
    Publication number: 20140194462
    Abstract: The present application is related to compounds represented by Formula I, which are novel allosteric modulators of ?7nAChR. The application also discloses the treatment of disorders that are responsive to modulation of acetylcholine action on ?7nAChR in a mammal by administering an effective amount of a compound of Formula I.
    Type: Application
    Filed: October 8, 2013
    Publication date: July 10, 2014
    Applicant: Anvyl LLC
    Inventor: Richard Kanner
  • ?-7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof
    Patent number: 8563579
    Abstract: The present application is related to compounds represented by Formula I, which are novel allosteric modulators of ?7nAChR. The application also discloses the treatment of disorders that are responsive to modulation of acetylcholine action on ?7nAChR in a mammal by administering an effective amount of a compound of Formula I.
    Type: Grant
    Filed: January 15, 2010
    Date of Patent: October 22, 2013
    Assignee: Anvyl LLC
    Inventor: Richard Kanner